HELLP syndrome and associated factors among pregnant women with preeclampsia/eclampsia at a referral hospital in southwestern Uganda: a cross-sectional study.
Humans
Female
HELLP Syndrome
/ epidemiology
Pregnancy
Uganda
/ epidemiology
Cross-Sectional Studies
Adult
Pre-Eclampsia
/ epidemiology
Eclampsia
/ epidemiology
Prevalence
Young Adult
Risk Factors
Referral and Consultation
/ statistics & numerical data
Platelet Count
Aspartate Aminotransferases
/ blood
Eclampsia
HELLP syndrome
Preeclampsia
Prevalence
Uganda
Journal
BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799
Informations de publication
Date de publication:
01 Oct 2024
01 Oct 2024
Historique:
received:
17
02
2024
accepted:
16
09
2024
medline:
2
10
2024
pubmed:
2
10
2024
entrez:
1
10
2024
Statut:
epublish
Résumé
Hemolysis Elevated Liver Enzymes Low Platelets (HELLP) syndrome, a complication of preeclampsia/eclampsia, is associated with severe maternal morbidity and mortality. In resource-limited settings, such as Uganda, gaps in routine laboratory assessments may lead to underdetection of HELLP syndrome. This study determined the prevalence and factors associated with HELLP syndrome among pregnant women with preeclampsia/eclampsia at Mbarara Regional Referral Hospital (MRRH), southwestern Uganda. A cross-sectional study was conducted at the high-risk ward of the MRRH from December 2022 to June 2023. Pregnant women diagnosed with preeclampsia or eclampsia were enrolled consecutively. Participants' sociodemographic and clinical data were collected using an interviewer-administered questionnaire. The diagnosis of complete HELLP syndrome was made based on the Tennessee classification: aspartate aminotransferase enzyme ≥ 70 IU/L, platelet counts < 100,000 cells/µL, and serum lactate dehydrogenase enzyme ≥ 600 IU/L. We used multivariable modified Poisson regression analysis to determine factors associated with HELLP syndrome. A total of 129 participants with a mean age of 28 ± 6.6 years were enrolled in the study. The prevalence of HELLP syndrome was 18.6% (n = 24; 95% CI: 12.7-26.3%). Independent factors associated with HELLP syndrome were maternal age (adjusted prevalence ratio [aPR]: 4.96; 95% CI: 1.57-15.65; for mothers aged < 20 years compared to those aged 20-34 years), the presence of epigastric pain (aPR: 5.89; 95% CI: 1.41-14.63), and referral from other health facilities (aPR: 3.14; 95% CI: 1.27-7.72). Approximately 2 of the 10 women who presented with preeclampsia or eclampsia had HELLP syndrome. It is more common among teenage mothers, those with a history of epigastric pain and those referred from lower health facilities. Incorporating routine laboratory testing for HELLP syndrome in the diagnostic protocol for preeclampsia or eclampsia, especially among adolescent mothers, those experiencing epigastric pain, and those referred from lower health facilities, could enhance timely detection and management of mothers with preeclampsia whose pregnancies are complicated by HELLP syndrome.
Sections du résumé
BACKGROUND
BACKGROUND
Hemolysis Elevated Liver Enzymes Low Platelets (HELLP) syndrome, a complication of preeclampsia/eclampsia, is associated with severe maternal morbidity and mortality. In resource-limited settings, such as Uganda, gaps in routine laboratory assessments may lead to underdetection of HELLP syndrome. This study determined the prevalence and factors associated with HELLP syndrome among pregnant women with preeclampsia/eclampsia at Mbarara Regional Referral Hospital (MRRH), southwestern Uganda.
METHODS
METHODS
A cross-sectional study was conducted at the high-risk ward of the MRRH from December 2022 to June 2023. Pregnant women diagnosed with preeclampsia or eclampsia were enrolled consecutively. Participants' sociodemographic and clinical data were collected using an interviewer-administered questionnaire. The diagnosis of complete HELLP syndrome was made based on the Tennessee classification: aspartate aminotransferase enzyme ≥ 70 IU/L, platelet counts < 100,000 cells/µL, and serum lactate dehydrogenase enzyme ≥ 600 IU/L. We used multivariable modified Poisson regression analysis to determine factors associated with HELLP syndrome.
RESULTS
RESULTS
A total of 129 participants with a mean age of 28 ± 6.6 years were enrolled in the study. The prevalence of HELLP syndrome was 18.6% (n = 24; 95% CI: 12.7-26.3%). Independent factors associated with HELLP syndrome were maternal age (adjusted prevalence ratio [aPR]: 4.96; 95% CI: 1.57-15.65; for mothers aged < 20 years compared to those aged 20-34 years), the presence of epigastric pain (aPR: 5.89; 95% CI: 1.41-14.63), and referral from other health facilities (aPR: 3.14; 95% CI: 1.27-7.72).
CONCLUSION
CONCLUSIONS
Approximately 2 of the 10 women who presented with preeclampsia or eclampsia had HELLP syndrome. It is more common among teenage mothers, those with a history of epigastric pain and those referred from lower health facilities. Incorporating routine laboratory testing for HELLP syndrome in the diagnostic protocol for preeclampsia or eclampsia, especially among adolescent mothers, those experiencing epigastric pain, and those referred from lower health facilities, could enhance timely detection and management of mothers with preeclampsia whose pregnancies are complicated by HELLP syndrome.
Identifiants
pubmed: 39354446
doi: 10.1186/s12884-024-06835-y
pii: 10.1186/s12884-024-06835-y
doi:
Substances chimiques
Aspartate Aminotransferases
EC 2.6.1.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
626Subventions
Organisme : Forgarty International Center of the National Institute of Health
ID : D43TW011401
Organisme : Cambridge Trust
ID : N/A
Organisme : Commonwealth Scholarship Commission
ID : N/A
Organisme : Foreign, Commonwealth and Development Office
ID : N/A
Informations de copyright
© 2024. The Author(s).
Références
Rakshit A, Lahiri S, Biswas SC, Dey R, Roy BR, Saha MM. A study to detect HELLP syndrome and partial HELLP syndrome among preeclamptic mothers and their impact on fetomaternal outcome. Al Ameen J Med Sci. 2014;7(1):20–5.
Khosravi S, Dabiran S, Lotfi M, Asnavandy MJOJPM. Study of the prevalence of hypertension and complications of hypertensive disorders in pregnancy. 2014;4(11):860–7.
Ngwenya SJIjowsh. Severe preeclampsia and eclampsia: incidence, complications, and perinatal outcomes at a low-resource setting, Mpilo Central Hospital, Bulawayo, Zimbabwe. 2017:353-7.
Mersha AG, Abegaz TM. Seid MAJBp, childbirth. Maternal and perinatal outcomes of hypertensive disorders of pregnancy in Ethiopia: systematic review and meta-analysis. 2019;19:1–12.
Gupta T, Gupta N, Jain J, Gupta S, Bhatia P, Bagla JJJUCMS. Maternal and perinatal outcome in patients with severe pre eclampsia/eclampsia with and without. HELLP Syndrome. 2013;1(4):7–12.
Lisonkova S, Razaz N, Sabr Y, Muraca G, Boutin A, Mayer C et al. Maternal risk factors and adverse birth outcomes associated with HELLP syndrome: a population-based study. 2020;127(10):1189–98.
Fitzpatrick KE, Hinshaw K, Kurinczuk JJ, Knight M. Risk factors, management, and outcomes of hemolysis, elevated liver enzymes, and low platelets syndrome and elevated liver enzymes, low platelets syndrome. Obstet Gynecol. 2014;123(3):618–27.
doi: 10.1097/AOG.0000000000000140
pubmed: 24499757
Bartal MF, Sibai BM. Eclampsia in the 21st century. Am J Obstet Gynecol. 2022;226(2):S1237–53.
doi: 10.1016/j.ajog.2020.09.037
Awor S, Byanyima R, Abola B, Nakimuli A, Orach CG, Kiondo P et al. Incidence of preeclampsia and retention to prenatal care in Northern Uganda. East Afr Med J. 2022;99(6).
Ahonen J, Nuutila M. [HELLP syndrome–severe complication during pregnancy]. Duodecim. 2012;128(6):569–77.
pubmed: 22506319
KINAY T, KAYIKÇIOĞLU F, KÜÇÜK C, Karakaya J. Severe preeclampsia versus HELLP syndrome: maternal and perinatal outcomes at < 34 and ≥ 34 weeks’ gestation. Balkan Med J. 2015;32(4):359–63.
doi: 10.5152/balkanmedj.2015.15777
pubmed: 26740894
pmcid: 4692334
Jjuuko M, Lugobe HM, Migisha R, Agaba DC, Tibaijuka L, Kayondo M, et al. Maternal near miss as a predictor of adverse perinatal outcomes: findings from a prospective cohort study in southwestern Uganda. BMC Pregnancy Childbirth. 2024;24(1):42.
doi: 10.1186/s12884-024-06244-1
pubmed: 38184536
pmcid: 10770958
OpenEpi: Open Source Epidemiologic Statistics for Public Health [Internet]. 2013 [cited 2022/03/30]. https://www.openepi.com/Menu/OE_Menu.htm
Lugobe HM, Muhindo R, Kayondo M, Wilkinson I, Agaba DC, McEniery C, et al. Risks of adverse perinatal and maternal outcomes among women with hypertensive disorders of pregnancy in southwestern Uganda. PLoS ONE. 2020;15(10):e0241207.
doi: 10.1371/journal.pone.0241207
pubmed: 33112915
pmcid: 7592727
Awuor E. Factors and clinical features associated with development of hellp syndrome among patients with preeclampsia with severe features at the. Kenyatta National Hospital: University of Nairobi; 2020.
Martin JN Jr., Rose CH, Briery CM. Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol. 2006;195(4):914–34.
doi: 10.1016/j.ajog.2005.08.044
pubmed: 16631593
Mersha AG, Abegaz TM, Seid MA. Maternal and perinatal outcomes of hypertensive disorders of pregnancy in Ethiopia: systematic review and meta-analysis. BMC Pregnancy Childbirth. 2019;19:1–12.
doi: 10.1186/s12884-019-2617-8
Liu C, Chang S, Cheng P. Comparison of referral and non-referral hypertensive disorders during pregnancy: an analysis of 271 consecutive cases at a tertiary hospital. Chang Gung Med J. 2005;28(5):326.
pubmed: 16086547
Dempsey A, Sripad P, Sultana K, Kirk K, Hossain SMI, Warren C. Pathways to service access for pre-eclampsia and eclampsia in rural Bangladesh: exploring women’s care-seeking. PLoS ONE. 2021;16(2):e0245371.
doi: 10.1371/journal.pone.0245371
pubmed: 33539410
pmcid: 7861535
Dusse LM, Alpoim PN, Silva JT, Rios DRA, Brandão AH, Cabral ACV. Revisiting HELLP syndrome. Clin Chim Acta. 2015;451:117–20.
doi: 10.1016/j.cca.2015.10.024
pubmed: 26525965
Struller F, Weinreich F-J, Horvath P, Kokkalis M-K, Beckert S, Königsrainer A, et al. Peritoneal innervation: embryology and functional anatomy. Pleura Peritoneum. 2017;2(4):153–61.
doi: 10.1515/pp-2017-0024
pubmed: 30911646
pmcid: 6328075